Losartan vir 100 mg comprimidos recubiertos con pelicula efg

Leaflet: information for the user

Losartán Vir 100 mg film-coated tablets

Read this leaflet carefully before you start taking the medicine.

• Keep this leaflet, as you may need to read it again.
• If you have any questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you. Do not pass it on to others even if their symptoms are the same. It may harm them.
• If you think you have suffered a side effect, you can report it directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. You can also report it via the MHRA's spontaneous reporting website when it is available.

1. What Losartán Vir is and what it is used for

2. Before taking Losartán Vir

3. How to take Losartán Vir

4. Possible side effects

5. Storage of Losartán Vir

6. Further information

Losartán belongs to a group of medications known as angiotensin II receptor antagonists.

Angiotensin II is a substance produced in the body that binds to receptors present in blood vessels, causing them to constrict. This results in an increase in blood pressure. Losartán prevents the binding of angiotensin II to these receptors, causing blood vessels to relax, which in turn reduces blood pressure. Losartán reduces the worsening of renal function in patients with high blood pressure and type 2 diabetes.

Losartán Vir is used for

• To treat patients with elevated blood pressure (hypertension).
• To protect the kidneys in hypertensive patients with type 2 diabetes and laboratory test results indicating renal insufficiency and proteinuria ≥ 0.5 g per day (a situation in which the urine contains an abnormal amount of proteins).
• To treat patients with chronic heart failure, when their doctor considers that treatment with specific medications, called angiotensin-converting enzyme inhibitors (ACE inhibitors, medications used to reduce elevated blood pressure) are not suitable. If their heart failure has been stabilized with an ACE inhibitor, they should not switch to losartán.
• In patients with elevated blood pressure and left ventricular hypertrophy of the heart, losartán has been shown to reduce the risk of stroke (LIFE indication).

Do not take Losartán Vir

• If you are allergic (hypersensitive) to losartan or any of the other components of Losartán Vir.
• If your liver function is severely damaged.
• If you are more than 3 months pregnant. (It is also best to avoid Losartán Vir during the first months of pregnancy – see Pregnancy section).
• If you have diabetes or kidney failure and are being treated with a blood pressure medication that contains aliskirén.

Be especially careful with Losartán Vir

Inform your doctor if you are pregnant (or if you suspect you may be). Losartán Vir is not recommended for use at the beginning of pregnancy, and in any case, it should not be administered if you are more than three months pregnant, as it may cause serious damage to your baby when administered from that point onwards (see Pregnancy section).

Before taking Losartán Vir, it is essential that you inform your doctor:

• If you have had a history of angioedema (swelling of the face, lips, tongue, and/or throat) (see also section 4. Possible side effects).
• If you have excessive vomiting or diarrhea, which cause excessive fluid and/or salt loss from your body.
• If you are taking diuretics (medications that increase the amount of water that passes through your kidneys) or if you are following a low-sodium diet that causes excessive fluid or salt loss from your body (see section 3. Dosage in special patient groups).
• If you know you have narrowing or blockage of the blood vessels leading to your kidneys or if you have recently undergone a kidney transplant.
• If your liver function is altered (see sections 2. Do not take Losartán Vir and 3. Dosage in special patient groups).
• If you have heart failure with or without kidney failure or potentially fatal cardiac arrhythmias. Special attention is required when being treated at the same time with a beta-blocker.
• If you have problems with your heart valves or heart muscle.
• If you have coronary heart disease (caused by reduced blood flow in the heart's blood vessels) or cerebrovascular disease (caused by reduced blood circulation in the brain).
• If you have primary hyperaldosteronism (a syndrome associated with elevated secretion of the hormone aldosterone by the adrenal gland due to an alteration of this gland).
• If you are taking any of the following medications used to treat high blood pressure (hypertension):

- an angiotensin-converting enzyme inhibitor (ACE inhibitor) (e.g. enalapril, lisinopril, ramipril), particularly if you have kidney problems related to diabetes.

- aliskirén.

• If you experience abdominal pain, nausea, vomiting, or diarrhea after taking losartan. Your doctor will decide whether to continue treatment. Do not stop taking losartán in monotherapy.

Your doctor may monitor your renal function, blood pressure, and electrolyte levels in your blood (e.g. potassium) at regular intervals.

See also the information under the heading “Do not take Losartán Vir”.

Use of other medications

Inform your doctor or pharmacist if you are taking or have recently taken other medications, including over-the-counter medications, herbal remedies, and natural products.

While taking Losartán Vir, be particularly cautious if you take any of the following medications:

• Other medications that lower blood pressure, as they may cause additional blood pressure reduction. Blood pressure may also decrease with some of the following medications/classes of medications: tricyclic antidepressants, antipsychotics, baclofen, amifostine.
• Medications that retain potassium or that may increase potassium levels (e.g. potassium supplements, salt substitutes containing potassium, or potassium-sparing medications such as certain diuretics [amiloride, triamterene, spironolactone] or heparin).
• Nonsteroidal anti-inflammatory drugs (NSAIDs), such as indomethacin, including COX-2 inhibitors (medications that reduce inflammation and may be used to relieve pain), as they may reduce the blood pressure-lowering effect of losartan.

Your doctor may need to modify your dosage and/or take other precautions:

If you are taking an ACE inhibitor or aliskirén (see also the information under the headings “Do not take Losartán Vir” and “Be especially careful with Losartán Vir”).

If your renal function is altered, the concomitant use of these medications may cause a worsening of renal function.

Lithium-containing medications should not be used in combination with losartán without your doctor's careful monitoring. It may be necessary to take special precautions (e.g. blood tests).

Taking Losartán Vir with food and beverages

Losartán Vir can be taken with or without food.

Pregnancy and breastfeeding

Pregnancy

You should inform your doctor if you are pregnant (or if you suspect you may be). Your doctor will usually recommend that you stop taking Losartán Vir before becoming pregnant or as soon as you know you are pregnant and will recommend that you take another medication instead of Losartán Vir. Losartán Vir is not recommended for use at the beginning of pregnancy, and in any case, it should not be administered if you are more than three months pregnant, as it may cause serious damage to your baby when administered from that point onwards.

Breastfeeding

Inform your doctor if you are breastfeeding or plan to start. Losartán Vir is not recommended for use during breastfeeding, and your doctor will choose another treatment for you if you wish to breastfeed, especially if your baby is newborn or premature.

Consult your doctor or pharmacist before using any medication.

Use in children and adolescents

Losartan has been studied in children. For more information, speak with your doctor.

Driving and operating machinery

No studies have been conducted on the effects on the ability to drive and operate machinery. It is unlikely that Losartán Vir will affect your ability to drive or operate machinery. However, as many medications used to treat high blood pressure, losartan may cause dizziness or drowsiness in some people. If you experience dizziness or drowsiness, consult your doctor before engaging in these activities.

Follow exactly the administration instructions for Losartán Vir as indicated by your doctor.

Your doctor will decide the appropriate dose of Losartán Vir, depending on your condition and if you are taking other medications. It is essential to continue taking Losartán Vir as prescribed by your doctor to maintain consistent blood pressure control.

Patients with high blood pressure

Typically, treatment begins with 50 mg of losartan (one Losartán Vir 50 mg tablet) once a day. The maximum blood pressure-lowering effect is achieved within 3-6 weeks of starting treatment. Subsequently, in some patients, the dose may be increased to 100 mg of losartan (1 Losartán Vir 100 mg tablet or 2 Losartán Vir 50 mg tablets) once a day.

If you estimate that the action of Losartán is too strong or too weak, please inform your doctor or pharmacist.

Patients with high blood pressure and type 2 diabetes

Typically, treatment begins with 50 mg of losartan (one Losartán Vir 50 mg tablet) once a day. Subsequently, the dose may be increased to 100 mg of losartan (1 Losartán Vir 100 mg tablet or 2 Losartán Vir 50 mg tablets) once a day, depending on your blood pressure response.

Losartan tablets can be taken with other medications that lower blood pressure (e.g., diuretics, calcium channel blockers, alpha or beta blockers, and central-acting medications), as well as with insulin and other frequently used medications to decrease blood glucose levels (e.g., sulfonylureas, glitazones, and glucosidase inhibitors).

Patients with heart failure

Typically, treatment begins with 12.5 mg of losartan (one Losartán 12.5 mg Initio tablet) once a day. Typically, the dose is gradually increased weekly (i.e., 12.5 mg per day for the first week, 25 mg per day for the second week, and 50 mg per day for the third week), up to a maintenance dose of 50 mg of losartan (1 Losartán Vir 50 mg tablet) once a day, as needed.

In the treatment of heart failure, losartan is typically combined with a diuretic (a medication that increases the amount of water that passes through your kidneys) and/or digitalis (a medication that helps your heart be stronger and more efficient) and/or a beta blocker.

Posology in special patient groups

Your doctor may recommend a lower dose, especially when starting treatment in certain patients, such as those treated with high doses of diuretics, patients with liver insufficiency, or patients over 75 years old. Losartan is not recommended for use in patients with severe liver insufficiency (see "Do not take Losartán Vir").

Administration

Tablets should be taken with a glass of water. You should try to take your daily dose at approximately the same time each day. It is essential to continue taking Losartán Vir until your doctor tells you otherwise.

If you take more Losartán Vir than you should

If you accidentally take too many tablets, or if a child swallows some, contact your doctor immediately. The symptoms of overdose are low blood pressure, increased heart rate, and possibly decreased heart rate.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.

If you forget to take Losartán Vir

If you accidentally forget a dose, simply take the next dose as usual. Do not take a double dose to compensate for the missed tablet.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Like all medications, Losartán Vir may cause side effects, although not everyone will experience them.

If you experience the following, stop taking the losartán tablets and inform your doctor immediately or go to the emergency service of your nearest hospital:

Severe allergic reaction (skin rash, itching, swelling of the face, lips, mouth, or throat that may cause difficulty swallowing or breathing).

This is a serious but rare side effect that affects more than 1 in 10,000 patients but fewer than 1 in 1,000. You may need urgent medical attention or hospitalization.

Medication side effects are classified as follows:

Very common:Affects 1 in 10 patients.

Common:Affects 1 to 10 patients in 100.

Uncommon:Affects 1 to 10 patients in 1,000.

Rare:Affects 1 to 10 patients in 10,000.

Very rare:Affects fewer than 1 in 10,000 patients.

Unknown:The frequency cannot be estimated from the available data.

The following side effects have been reported with losartán:

Common:

• Dizziness,
• Low blood pressure,
• Weakness,
• Fatigue,
• Low blood sugar (hypoglycemia),
• High potassium levels in the blood (hyperkalemia).

Uncommon:

• Drowsiness,
• Headache,
• Sleep disturbances,
• Feeling of very rapid heartbeats (palpitations),
• Severe chest pain (angina pectoris),
• Low blood pressure (especially after excessive loss of body water from the blood vessels, e.g., in patients with severe heart failure or on high doses of diuretics),
• Orthostatic effects related to the dose, such as decreased blood pressure after standing up from lying or sitting,
• Difficulty breathing (dyspnea),
• Abdominal pain,
• Chronic constipation,
• Diarhea,
• Nausea
• Vomiting,
• Hives (urticaria),
• Itching (pruritus),
• Skin rash,
• Localized swelling (edema).

Rare:

• Inflammation of the blood vessels (vasculitis, Schonlein-Henoch purpura),
• Numbness or tingling (paresthesia),
• Fainting (syncope),
• Very rapid and irregular heartbeats (atrial fibrillation), stroke (cerebrovascular accident),
• Inflammation of the liver (hepatitis),
• Elevation of alanine aminotransferase (ALT) levels in the blood, which usually resolves upon discontinuing treatment.
• Intestinal angioedema: swelling in the intestine presenting symptoms such as abdominal pain, nausea, vomiting, and diarrhea.

Unknown:

• Reduced number of red blood cells (anemia),
• Reduced number of platelets,
• Migraine,
• Cough,
• Liver function abnormalities,
• Muscle and joint pain,
• Changes in kidney function (may be reversible upon discontinuing treatment), including renal insufficiency,
• Symptoms similar to the flu,
• Increased urea, creatinine, and potassium levels in the blood in patients with heart failure,
• Back pain and urinary tract infection.

Reporting of side effects:

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

Keep out of the reach and sight of children.

Do not use Losartán Vir after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.

No special storage conditions are required.

Store Losartán Vir in the original packaging.

Do not open the blister until you are ready to take the medication.

Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and unused medicines at the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medicines. By doing so, you will help protect the environment.

Composition of Losartán Vir

The active ingredient of Losartán Vir is losartan potassium.

Each Losartán Vir 100 mg tablet contains 100 mg of losartan potassium.

The other components of the core are microcrystalline cellulose, stearate of sodium, sodium croscarmellose, and anhydrous colloidal silica.

Losartán Vir 100 mg contains potassium in the following amount: 8.48 mg (0.216 mEq).

The other components of the coating are microcrystalline cellulose, hydroxypropylmethylcellulose, polyoxyl 40 stearate, and titanium dioxide (E171).

Appearance of the product and contents of the package

Losartán Vir 100 mg is supplied as film-coated tablets, white, oblong, and biconvex without a notch.

Losartán Vir is supplied in the following package sizes: Blister PVC/PE/PVDC/Al, in packages of 28 film-coated tablets.

Holder of the marketing authorization and responsible for manufacturing

Holder of the Marketing Authorization:

Industria Química y Farmacéutica VIR, S.A.

C/Laguna 66-68-70

Polígono Industrial Urtinsa II

28923 Alcorcón-Madrid (Spain)

Responsible for manufacturing:

Sofarimex Lda.

Av. Indústrias, Alto do Colaride

Agualva 2735-213 Cacém – Portugal

or

Industria Química y Farmacéutica VIR, S.A.

C/ Laguna 66-68-70

Polígono Industrial Urtinsa II

28923 Alcorcón-Madrid (Spain)

This leaflet was approved in February 2025

The detailed and updated information of this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/.